Neonatology in Singapore: The way we were, the way forward

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 3, 2003, Pages 311-317

  Ho, N K ^a,b  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b 07 02 The Paragon   (Singapore)

Author keywords

G6PD screening; Kandang Kerbau (maternity) Hospital; Kernicterus; OSIRIS trial; Surfactant replacement therapy

Indexed keywords

ALLOPURINOL; BLOOD SUBSTITUTE; DEFEROXAMINE; DNA VACCINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MAGNESIUM SULFATE; PHENOBARBITAL; SURFACTANT;

ARTIFICIAL VENTILATION; CLINICAL PRACTICE; CONFERENCE PAPER; EXCHANGE BLOOD TRANSFUSION; GENE THERAPY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HYALINE MEMBRANE DISEASE; INTENSIVE CARE UNIT; KERNICTERUS; MEDICAL GENETICS; MEDICAL SPECIALIST; MOLECULAR CLONING; MORTALITY; NEONATOLOGY; NEUROPROTECTION; NEWBORN; NEWBORN CARE; NEWBORN HYPOXIA; NEWBORN JAUNDICE; NEWBORN SEPSIS; PATIENT MONITORING; PHOTOTHERAPY; PREMATURITY; SCREENING; SINGAPORE; SOCIAL STATUS;

EID: 0041517683     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Wong H B. Hyperbilirubinemia and kernicterus in Singapore. J Singapore Paediatr Soc 1964; 6:1-6.
2. Brown W R, Boon W H. Hyperbilirubinemia and kernicterus in glucose-6-phosphate dehydrogenase-deficient infants in Singapore. Pediatrics 1968; 41:1055-62.
3. Wong H B. A surveillance system to prevent kernicterus in Singapore infants. J Singapore Paediatr Soc 1975; 17:1-9.
4. Ho N K. Neonatal jaundice in Asia. In: Fleming A F, editor. Bailliere's Clinical Haematology - Epidemiology of Haematological Disease. Part 1. London: Bailliere Tindall, 1992; 5:131-42.
5. Diamond L K. Replacement transfusion as a treatment for erythroblastosis foetalis. Pediatrics 1948; 2:520.
6. Diamond L K. Historic perspective on 'exchange transfusion'. Vox Sang 1983; 45:333-5.
7. Silverman W A, Sinclair J C. Infants of low birth weight. N Engl J Med 1966; 274:448-50.
8. Ho N K, Lim S B. Outcome of infants weighing 500-999 grams at birth in a Singapore hospital (1990-1993). Singapore Med J 1995; 36:185-8.
9. Ho N K. Outcome of the extremely low birth weight infants (less than 999 grams): what messages are we getting? Singapore Med J 1995; 36:527-31.
10. Gregory G A, Kitterman J A, Phibbs R H, Tooley W H, Hamilton W K. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284:1333-40.
11. Avery M E, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959; 97:517-23.
12. Chu J, Clements J A, Cotton E K, Klaus M H, Sweet A Y, Tooley W H, et al. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics 1967; 40(Suppl):709-82
13. Enhorning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972; 50:58-66.
14. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; 1:55-9.
15. Ho N K. Surfactant replacement therapy: the Singapore experience. J Singapore Paediatr Soc 1993; 35:58-67.
16. The OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS. Lancet 1992; 340:1363-8.
17. Robertson N J, Edwards A D. Recent advances in developing neuroprotective strategies for perinatal asphyxia. Curr Opin Pediatr 1998; 10:575-80.
18. Ho N K. Decision-making: initiation and withdrawing life support in the asphyxiated infants in developing countries. Singapore Med J 2001; 42:402-5.
19. Clark R H. The safe introduction of new technologies into neonatal medicine. Clin Perinatol 1996; 23:519-27.
20. Lam B C. Surfactant lavage for the management of severe meconium aspiration syndrome. Biol Neonate 1999; 76(Suppl 1): 10-4.
21. Soll R F, Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev 2000; 2:CD002054.
22. Wiswell T E, Knight G R, Finer N N, Donn S M, Desai H, Walsh W F, et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109:1081-7.
23. Rajadurai V S, Koh P L, Goh S Y, Ng K, Chew S Y. Surfactant therapy in large preterm and full-term infants with respiratoy failure: experience over a decade. Handbook of the 6th Annual Congress of Perinatal Society of Australia and New Zealand and the 12th Congress of Federation of the Asia and Oceania Perinatal Societies; 2002 March 9-13; New Zealand. New Zealand: Christchurch, 2002:74.
24. Barrington K J, Finer N N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2001;(4):CD000509.
25. Starfield B. Medical errors and adverse effects. Br J Gen Pract 2001; 51:232.
26. Johnson L J. How to avoid medication errors. Med Econ 2001; 78: 137
27. Wolke D. Environmental neonatology. Arch Dis Child 1987; 62:987-8.
28. Blackburn S. Environmental impact of the NICU on developmental outcomes. J Pediatr Nurs 1998; 13:279-89.
29. Anand K J. Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med 2001; 155:173-80.
30. Ho N K. Congenital malformations in Toa Payoh Hospital - a 18 year experience (1972-1989). Ann Acad Med Singapore 1991; 20:183-9.
31. Gadow E C, Otano L, Lippold S E. Congenital malformations. Curr Opin Obstet Gynecol 1996; 8:412-6.
32. Heng S K, Ho N K. Morbidity in infants of mother with gestational diabetes mellitus in an Asian population. Singapore Paediatr J 1995; 37:257-61.
33. Ho N K. A study of 8 year neonatal deaths (1982-1989) of Toa Payoh Hospital. Singapore Med J 1991; 32:138-41.
34. Ho N K. Ethical issues of neonatal paediatrics - the Singapore perspective. Ann Acad Med Singapore 1995; 24:910-4.
35. Poland G A, Murray D, Bonilla-Guerrero R. New vaccine development. BMJ 2002; 324:1315-9.
36. Oon C J. DNA vaccines - prospects for the future. JAMA SEA 1999; 15:5-7.
37. Pachuk C J, McCallus D E, Weiner D B, Satishchandran C. DNA vaccines - challenges in delivery. Curr Opin Mol Ther 2000; 2:188-98.
38. Assil K K, Hartzer M, Weinreb R N, Nehorayan M, Ward T, Blumenkranz M. Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Invest Ophthalmol Vis Sci 1991; 32:2891-7
39. Garcia M G, Hutson A D, Christensen R D. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 2002; 22:108-11.
40. Freitas R A Jr. Exploratory design in medical nanotechnology: a mechanical artificial red cell. Artif Cells Blood Substit Immobil Biotechnol 1998; 26:411-30.
41. Ho N K. Appropriate technologies in neonatal care in the developing countries. Singapore Paediatr J 1997; 39:162-9.
42. Ho N K. Relevance of neonatal care in developing countries [editorial]. Singapore Med J 1998; 40:558-60.